Tristel PLC (TSTL)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

420.00p

Buy

425.00p

arrow-down-3.45p (-0.81%)

Prices updated at 19 Dec 2025, 13:24 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Tristel PLC is a medical instruments manufacturer. Its products include infection prevention and contamination control equipment used in various medical settings.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
-
CEO
Mr. Matthew Giovanni Sassone
Most recent earnings
30 Jun 2025
Fiscal year end
30 Jun 2025
Employees
267
Head office
Fordham Road
Snailwell
United Kingdom
CB8 7NY
mobile
+44 1638721500
letter
mail@tristel.com

Key personnel

Salary
Mr. Tom Arthur John Jenkins
Non-Executive Director, Senior Independent Non-Executive Director
-
Ms. Isabel Josephine Sutherland Napper
Non-Executive Director
-
Ms. Caroline Jane Stephens
Non-Executive Director
-
Mr. Matthew Giovanni Sassone
Executive Director, Chief Executive Officer
-

Top 5 shareholders

No. of shares
Liontrust Investment Partners LLP4,365,828
Liontrust UK Smaller Companies Fund3,970,541
Unicorn Asset Management Ltd2,505,377
Unicorn AIM VCT Series 3 ORD1,635,329
Montanaro UK Sm Co Inv Tr1,000,000

Director dealings

Action
11 Dec 2025Purchase
01 Apr 2025Purchase
26 Mar 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.